UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

Mitofusin-2 triggers mitochondria Ca2+ influx from the endoplasmic reticulum to induce apoptosis in hepatocellular carcinoma cells

Cancer letters, 2015-03, Vol.358 (1), p.47-58

2015

Link zum Volltext

Verfügbarkeit prüfen

Androgen deprivation of prostate cancer: Leading to a therapeutic dead end

Cancer letters, 2015-10, Vol.367 (1), p.12-17

2015

Link zum Volltext

Verfügbarkeit prüfen

Transforming growth factor-β-induced epithelial-mesenchymal transition facilitates epidermal growth factor-dependent breast cancer progression

Oncogene, 2010-12, Vol.29 (49), p.6485-6498

2010

Link zum Volltext

Verfügbarkeit prüfen

Bystander killing effect of DS‐8201a, a novel anti‐human epidermal growth factor receptor 2 antibody–drug conjugate, in tumors with human epidermal growth factor receptor 2 heterogeneity

Cancer science, 2016-07, Vol.107 (7), p.1039-1046

2016

Link zum Volltext

Verfügbarkeit prüfen

HIF1α and HIF2α: sibling rivalry in hypoxic tumour growth and progression

Nature reviews. Cancer, 2012-01, Vol.12 (1), p.9

2012

Link zum Volltext

Verfügbarkeit prüfen

Vascular Endothelial Growth Factor-Mediated Decrease in Plasma Soluble Vascular Endothelial Growth Factor Receptor-2 Levels as a Surrogate Biomarker for Tumor Growth

Cancer research (Chicago, Ill.), 2008-01, Vol.68 (2), p.521-529

2008

Link zum Volltext

Verfügbarkeit prüfen

Targeting Angiogenesis in Cancer Therapy: Moving Beyond Vascular Endothelial Growth Factor

The oncologist (Dayton, Ohio), 2015-06, Vol.20 (6), p.660-673

2015

Link zum Volltext

Verfügbarkeit prüfen

A comparative study of the effects of concentrated growth factors in two different forms on osteogenesis in vitro

Molecular medicine reports, 2019-08, Vol.20 (2), p.1039-1048

2019

Link zum Volltext

Verfügbarkeit prüfen

Sensitivities to various epidermal growth factor receptor‐tyrosine kinase inhibitors of uncommon epidermal growth factor receptor mutations L861Q and S768I: What is the optimal epidermal growth factor receptor‐tyrosine kinase inhibitor?

Cancer science, 2016-08, Vol.107 (8), p.1134-1140

2016

Link zum Volltext

Verfügbarkeit prüfen

Osimertinib regressed an EGFR-mutant lung-adenocarcinoma bone-metastasis mouse model and increased long-term survival

Translational oncology, 2020-10, Vol.13 (10), p.100826-100826, Article 100826

2020

Link zum Volltext

Verfügbarkeit prüfen

Edema Control by Cediranib, a Vascular Endothelial Growth Factor Receptor–Targeted Kinase Inhibitor, Prolongs Survival Despite Persistent Brain Tumor Growth in Mice

Journal of clinical oncology, 2009-05, Vol.27 (15), p.2542-2552

2009

Link zum Volltext

Verfügbarkeit prüfen

MET Kinase Inhibitor SGX523 Synergizes with Epidermal Growth Factor Receptor Inhibitor Erlotinib in a Hepatocyte Growth Factor―Dependent Fashion to Suppress Carcinoma Growth

Cancer research (Chicago, Ill.), 2010-09, Vol.70 (17), p.6880-6890

2010

Link zum Volltext

Verfügbarkeit prüfen

Fibroblast growth factor 18 promotes the growth, migration and invasion of MDA‑MB‑231 cells

Oncology reports, 2018-08, Vol.40 (2), p.704-714

2018

Link zum Volltext

Verfügbarkeit prüfen

Inhibition of the bone morphogenetic protein pathway suppresses tumor growth through downregulation of epidermal growth factor receptor in MEK/ERK‐dependent colorectal cancer

Cancer science, 2023-09, Vol.114 (9), p.3636-3648

2023

Link zum Volltext

Verfügbarkeit prüfen

Acetyl-11 -Keto-β-Boswellic Acid Inhibits Prostate Tumor Growth by Suppressing Vascular Endothelial Growth Factor Receptor 2-Mediated Angiogenesis

Cancer research (Chicago, Ill.), 2009-07, Vol.69 (14), p.5893-5900

2009

Link zum Volltext

Verfügbarkeit prüfen

Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in the Treatment of Epidermal Growth Factor Receptor―Mutant Non―Small Cell Lung Cancer Metastatic to the Brain

Clinical cancer research, 2012-02, Vol.18 (4), p.938-944

2012

Link zum Volltext

Verfügbarkeit prüfen

Vascular Endothelial Growth Factor Receptor-1 Contributes to Resistance to Anti–Epidermal Growth Factor Receptor Drugs in Human Cancer Cells

Clinical cancer research, 2008-08, Vol.14 (16), p.5069-5080

2008

Link zum Volltext

Verfügbarkeit prüfen

Fibroblast growth factor signals regulate transforming growth factor‐β‐induced endothelial‐to‐myofibroblast transition of tumor endothelial cells via Elk1

Molecular oncology, 2019-08, Vol.13 (8), p.1706-1724

2019

Link zum Volltext

Verfügbarkeit prüfen

miR-21-mediated tumor growth

Oncogene, 2007-04, Vol.26 (19), p.2799-2803

2007

Link zum Volltext

Verfügbarkeit prüfen

Membrane‐anchored growth factors, the epidermal growth factor family: Beyond receptor ligands

Cancer science, 2008-02, Vol.99 (2), p.214-220

2008

Link zum Volltext

Verfügbarkeit prüfen

Osteopontin Promotes Vascular Endothelial Growth Factor-Dependent Breast Tumor Growth and Angiogenesis via Autocrine and Paracrine Mechanisms

Cancer research (Chicago, Ill.), 2008, Vol.68 (1), p.152-161

2008

Link zum Volltext

Verfügbarkeit prüfen

A novel, potent, and selective insulin-like growth factor-I receptor kinase inhibitor blocks insulin-like growth factor-I receptor signaling in vitro and inhibits insulin-like growth factor-I receptor–dependent tumor growth in vivo

Molecular cancer therapeutics, 2007-08, Vol.6 (8), p.2158-2167

2007

Link zum Volltext

Verfügbarkeit prüfen

Novel Abs targeting the N‐terminus of fibroblast growth factor 19 inhibit hepatocellular carcinoma growth without bile‐acid‐related side‐effects

Cancer science, 2020-05, Vol.111 (5), p.1750-1760

2020

Link zum Volltext

Verfügbarkeit prüfen

Lessons from anti-vascular endothelial growth factor and anti-vascular endothelial growth factor receptor trials in patients with glioblastoma

Journal of clinical oncology, 2015-04, Vol.33 (10), p.1197-1213

2015

Link zum Volltext

Verfügbarkeit prüfen

The LKB1-AMPK pathway: metabolism and growth control in tumour suppression

Nature reviews. Cancer, 2009-08, Vol.9 (8), p.563-575

2009

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 604.301

Suche als RSS-Feed

Aktive Filter

ThemaOncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(544.618)
Mit Volltextzugriff
(557.166)

Publikationsform

7 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(602.855)
Japanisch
(96.608)
Deutsch
(961)
Französisch
(519)
Polnisch
(363)
Norwegisch
(322)
Chinesisch
(209)
Russisch
(174)
Portugiesisch
(123)
Spanisch
(70)
Türkisch
(51)
Urdu
(11)
Italienisch
(10)
Koreanisch
(7)
Schwedisch
(2)
Tschechisch
(1)
Niederländisch
(1)
Estnisch
(1)
Slowakisch
(1)
Welsh
(1)

15 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(572.802)
Life Sciences & Biomedicine
(567.259)
Humans
(383.681)
Female
(194.796)
Tumors
(166.204)
Male
(139.382)
Animals
(128.426)
Biological And Medical Sciences
(118.360)
Cancer
(114.518)
Middle Aged
(111.698)
Cancer Research
(108.308)
Medical Sciences
(107.301)
Aged
(92.921)
Adult
(87.418)
Mice
(81.592)
Medicine
(75.307)
Chemotherapy
(74.426)
Prognosis
(73.180)
Metastasis
(71.024)

14 weitere anzeigen...

Weniger anzeigen...

Kollektion

Electronic Journals Library
(365.757)
Journals@Ovid Complete
(270.341)
Ingenta
(263.372)
IngentaConnect Journals
(152.033)
Springer Nature - Complete Springer Journals
(143.716)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(95.824)
Wiley Online Library - AutoHoldings Journals
(86.412)
Single Journals
(83.345)
Single Title from Nature Journals
(62.683)
Elsevier ScienceDirect Journals Complete
(61.652)
Nexis Uni
(60.987)
Wiley Online Library Full Collection 2018
(58.592)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(43.249)
Oxford University Press Journals Current
(20.562)
Taylor & Francis Current Content Access
(16.787)
Oxford Journals 2020 Medicine
(16.119)
SAGE Publications
(15.596)
Taylor & Francis:Master (3349 titles)
(15.184)
SpringerLink Series
(14.859)
Ebook Central Perpetual and DDA
(7.441)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Cancers
(24.633)
Oncogene
(19.928)
Cancer Research
(19.697)
British Journal Of Cancer
(17.962)
International Journal Of Cancer
(17.043)
Annals Of Surgical Oncology
(16.842)
Bmc Cancer
(13.582)
Cancer
(13.130)
Cancer Letters
(10.239)
Leukemia
(10.107)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Mitofusin-2 triggers mitochondria Ca2+ influx from the endoplasmic reticulum to induce apoptosis in hepatocellular carcinoma cells

Androgen deprivation of prostate cancer: Leading to a therapeutic dead end

Transforming growth factor-β-induced epithelial-mesenchymal transition facilitates epidermal growth factor-dependent breast cancer progression

Bystander killing effect of DS‐8201a, a novel anti‐human epidermal growth factor receptor 2 antibody–drug conjugate, in tumors with human epidermal growth factor receptor 2 heterogeneity

HIF1α and HIF2α: sibling rivalry in hypoxic tumour growth and progression

Vascular Endothelial Growth Factor-Mediated Decrease in Plasma Soluble Vascular Endothelial Growth Factor Receptor-2 Levels as a Surrogate Biomarker for Tumor Growth

Targeting Angiogenesis in Cancer Therapy: Moving Beyond Vascular Endothelial Growth Factor

A comparative study of the effects of concentrated growth factors in two different forms on osteogenesis in vitro

Sensitivities to various epidermal growth factor receptor‐tyrosine kinase inhibitors of uncommon epidermal growth factor receptor mutations L861Q and S768I: What is the optimal epidermal growth factor receptor‐tyrosine kinase inhibitor?

Osimertinib regressed an EGFR-mutant lung-adenocarcinoma bone-metastasis mouse model and increased long-term survival

Edema Control by Cediranib, a Vascular Endothelial Growth Factor Receptor–Targeted Kinase Inhibitor, Prolongs Survival Despite Persistent Brain Tumor Growth in Mice

MET Kinase Inhibitor SGX523 Synergizes with Epidermal Growth Factor Receptor Inhibitor Erlotinib in a Hepatocyte Growth Factor―Dependent Fashion to Suppress Carcinoma Growth

Fibroblast growth factor 18 promotes the growth, migration and invasion of MDA‑MB‑231 cells

Inhibition of the bone morphogenetic protein pathway suppresses tumor growth through downregulation of epidermal growth factor receptor in MEK/ERK‐dependent colorectal cancer

Acetyl-11 -Keto-β-Boswellic Acid Inhibits Prostate Tumor Growth by Suppressing Vascular Endothelial Growth Factor Receptor 2-Mediated Angiogenesis

Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in the Treatment of Epidermal Growth Factor Receptor―Mutant Non―Small Cell Lung Cancer Metastatic to the Brain

Vascular Endothelial Growth Factor Receptor-1 Contributes to Resistance to Anti–Epidermal Growth Factor Receptor Drugs in Human Cancer Cells

Fibroblast growth factor signals regulate transforming growth factor‐β‐induced endothelial‐to‐myofibroblast transition of tumor endothelial cells via Elk1

miR-21-mediated tumor growth

Membrane‐anchored growth factors, the epidermal growth factor family: Beyond receptor ligands

Osteopontin Promotes Vascular Endothelial Growth Factor-Dependent Breast Tumor Growth and Angiogenesis via Autocrine and Paracrine Mechanisms

A novel, potent, and selective insulin-like growth factor-I receptor kinase inhibitor blocks insulin-like growth factor-I receptor signaling in vitro and inhibits insulin-like growth factor-I receptor–dependent tumor growth in vivo

Novel Abs targeting the N‐terminus of fibroblast growth factor 19 inhibit hepatocellular carcinoma growth without bile‐acid‐related side‐effects

Lessons from anti-vascular endothelial growth factor and anti-vascular endothelial growth factor receptor trials in patients with glioblastoma

The LKB1-AMPK pathway: metabolism and growth control in tumour suppression

Aktive Filter

Suchergebnisse filtern